The Wide and Complex Field of NAFLD Biomarker Research: Trends

Table 1

Definition of subtypes for data analysis.

(1) Control related to (1) NAFLD-NASH	(1) NAFLD-NASH contained healthy subjects (as defined and docusmented in the relevant studies), while the disease group consisted of NAFLD patients defined by the authors themselves.
(2) Control related to (2) NASH	(2) NASH comprised of NAFLD without NASH subjects, while NASH group consisted of NASH patients as defined by the authors themselves.
(3) Control related to (3) DM	(3) DM consisted of subjects without diabetes, while the disease group comprised of DM patients according to the publications.
(4) Control related to (4) MetSy	(4) MetSy—although initially considered for our statistical grouping—was omitted because of its inconsistent definition and inefficient available data.